(6) Actelion reports results of exploratory study with macitentan in IPF patients
29 August 2011 - No difference being observed between placebo and macitentan with regard to liver enzyme elevations.
http://www.actelion.com/en/investors/media-releases/index.page?newsId=1541790

(7) Capsugel Now a Standalone Business
Aug. 1, 2011 - Pfizer Inc. announced today that it has completed the sale of its Capsugel business to an affiliate of Kohlberg Kravis Roberts & Co. L.P.
http://capsugel.com/en/news-events/news/capsugel-now-a-standalone-busines/

(8) YM BioSciences JAK Inhibitor CYT387 Shown Active in Multiple Myeloma
Aug. 4, 2011 - CYT387 suppresses multiple signaling pathways, prevents proliferation and induces apoptosis in myeloma cells
http://www.ymbiosciences.com/investors/press_releases_item.php?newsid=1593265

(9) Chemaphor expands companion animal studies program
July 12, 2011 - New funding will support next round of OxC-beta studies in dogs, cats and horses.
http://www.chemaphor.com/news/CFR%20July%2012%202011.pdf

7th Annual Pharmaceutical Meeting Management Forum
March 27-29, 2011 Philadelphia, Pennsylvania An educational conference dedicated to the professional development needs of meeting and procurement professionals in the pharmaceutical industry.
http://www.cbinet.com/conference/pc11086

About Pycnogenol
Pycnogenol Information
http://www.pycnogenol.net

Acaros Bacterias Esporas Hongos Polen Polvo
Combata los enemigos invisibles, enemigos de los alergicos, asmaticos, etc.
http://acaro.8k.com

Actelion announces change in its Board of Directors
02 August 2011 - Actelion announced today that Joseph C. Scodari - for personal reasons - has resigned from Actelion's Board of Directors at the beginning of August 2011.
http://www.actelion.com/en/our-company/news-and-events/index.page?newsId=1535457

Actelion Announces Change in its Management Structure
Otto Schwarz appointed Chief Operating Officer.
http://www.actelion.com/en/our-company/news-and-events/index.page?newsId=1521550

Actelion announces Half Year 2011 financial results
ALLSCHWIL/BASEL, SWITZERLAND - 21 July 2011 - Actelion Ltd (SIX: ATLN) today announced its financial results for the first half of 2011
http://www.actelion.com/en/investors/media-releases/index.page?newsId=1532368

Anterior

1

2

3

4

5

6

7

8

9

Siguiente